^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ABM-168
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
ABM Therap
Drug class:
MEK1 inhibitor, MEK2 inhibitor
Related drugs:
Phase 1
ABM Therapeutics Corporation
Recruiting
Last update posted :
01/10/2024
Initiation :
03/30/2023
Primary completion :
10/16/2025
Completion :
10/16/2025
CD4
|
ABM-168
Share
